Skip to main content
Log in

S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells

  • Research Article
  • Published:
Molecules and Cells

Abstract

S100A8 and S100A9 (S100A8/A9) are low-molecular weight members of the S100 family of calcium-binding proteins. Recent studies have reported S100A8/A9 promote tumorigenesis. We have previously reported that S100A8/A9 is mostly expressed in stromal cells and inflammatory cells between gastric tumor cells. However, the role of environmental S100A8/A9 in gastric cancer has not been defined. We observed in the present study the effect of S100A8/A9 on migration and invasion of gastric cancer cells. S100A8/ A9 treatment increased migration and invasionat lower concentrations that did not affect cell proliferation and cell viability. S100A8/A9 caused activation of p38 mitogenactivated protein kinase (MAPK) and nuclear factor-κB (NF-κB). The phosphorylation of p38 MAPK was not affected by the NF-κB inhibitor Bay whereas activation of NF-κB was blocked by p38 MAPK inhibitor SB203580, indicating that S100A8/A9-induced NF-κB activation is mediated by phosphorylation of p38 MAPK. S100A8/A9-induced cell migration and invasion was inhibited by SB203580 and Bay, suggesting that activation of p38 MAPK and NF-κB is involved in the S100A8/A9 induced cell migration and invasion. S100A8/A9 caused an increase in matrix metalloproteinase 2 (MMP2) and MMP12 expression, which were inhibited by SB203580 and Bay. S100A8/A9-induced cell migration and invasion was inhibited by MMP2 siRNA and MMP12 siRNA, indicating that MMP2 and MMP12 is related to the S100A8/A9 induced cell migration and invasion. Taken together, these results suggest that S100A8/A9 promotes cell migration and invasion through p38 MAPKdependent NF-κB activation leading to an increase of MMP2 and MMP12 in gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Aggarwal, B.B. (2004). Nuclear factor-kappaB: the enemy within. Cancer Cell 6, 203–208.

    Article  PubMed  CAS  Google Scholar 

  • Ang, C.W., Nedijadi, T.A., Sheikh, A.M., Tweedle, E., Tonack, S., Honap, S.E., Jenkins, R., Park, B.K., Schwarte-Waldhoff, I., Khattak, I., et al. (2010). Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells. Carcinogenesis 31, 1541–1551.

    Article  PubMed  CAS  Google Scholar 

  • Choi, J.H., Shin, N.R., Moon, H.J., Kwon, C.H., Kim, G.H., Song, G.A., Jeon, T.Y., Kim, D.H., and Park, D.Y. (2012). Identification of S100A8 and S100A9 as negative regulators for lymph node metastasis of gastric adenocarcinoma. Histol. Histopathol. 27, 1439–1448.

    PubMed  CAS  Google Scholar 

  • Dong, W., Li, H., Zhang, Y., Yang, H., Guo, M., Li, L., and Liu, T. (2011). Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer. Acta Biochim. Biophys. Sin. 43, 840–848.

    Article  PubMed  CAS  Google Scholar 

  • Egeblad, M., and Werb, Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161–174.

    Article  PubMed  CAS  Google Scholar 

  • Foell, D., Wittkowski, H., Vogl, T., and Roth, J. (2007). S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol. 81, 28–37.

    Article  PubMed  CAS  Google Scholar 

  • Gebhardt, C., Nemeth, J., Angel, P., and Hess, J. (2006). S100A8 and S100A9 in inflammation and cancer. Biochem. Pharmacol. 72, 1622–1631.

    Article  PubMed  CAS  Google Scholar 

  • Gebhardt, C., Riehl, A., Durchdewald, M., Nemeth, J., Furstenberger, G., Muller-Decker, K., Enk, A., Arnold, B., Bierhaus, A., Nawroth, P.P., et al. (2008). RAGE signaling sustains inflammation and promotes tumor development. J. Exp. Med. 205, 275–285.

    Article  PubMed  CAS  Google Scholar 

  • Ghavami, S., Kerkhoff, C., Los, M., Hashemi, M., Sorg, C., and Karami-Tehrani, F. (2004). Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions. J. Leukoc. Biol. 76, 169–175.

    Article  PubMed  CAS  Google Scholar 

  • Ghavami, S., Kerkhoff, C., Chazin, W.J., Kadkhoda, K., Xiao, W., Zuse, A., Hashemi, M., Eshraghi, M., Schulze-Osthoff, K., Klonisch, T., et al. (2008a). S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. Biochim. Biophys. Acta. 1783, 297–311.

    Article  PubMed  CAS  Google Scholar 

  • Ghavami, S., Rashedi, I., Dattilo, B.M., Eshraghi, M., Chazin, W.J., Hashemi, M., Wesselborg, S., Kerkhoff, C., and Los, M. (2008b). S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J. Leukocyte Biol. 83, 1484–1492.

    Article  PubMed  CAS  Google Scholar 

  • Ghavami, S., Chitayat, S., Hashemi, M., Eshraghi, M., Chazin, W.J., Halayko, A.J., and Kerkhoff, C. (2009). S100A8/A9: a Janusfaced molecule in cancer therapy and tumorgenesis. Eur. J. Pharmacol. 625, 73–83.

    Article  PubMed  CAS  Google Scholar 

  • Hermani, A., De Servi, B., Medunganin, S., Tessier, P.A., and Mayer, D. (2006). S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp. Cell. Res. 312, 184–197.

    Article  PubMed  CAS  Google Scholar 

  • Hiratsuka, S., Watanabe, A., Aburantani, H., and Maru, Y. (2006). Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 8, 1369–1375.

    Article  PubMed  CAS  Google Scholar 

  • Hiratsuka, S., Watanabe, A., Sakurai, Y., Akashi-Takamura, S., Ishibashi, S., Miyake K., Shibuya, M., Akira, S., Aburatani, H., and Maru, Y. (2008). The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat. Cell Biol. 10, 1349–1355.

    Article  PubMed  CAS  Google Scholar 

  • Hofmann, H.S., Hansen, G., Richter, G., Taege, C., Simm, A., Silber, R.E., and Burdach, S. (2005). Matrixproteinase-12 expression correlates with local recurrence and metastatic desease in non-small cell lung cancer patients. Clin. Cancer Res. 11, 1086–1092.

    PubMed  CAS  Google Scholar 

  • Ichikawa, M., Williams, R., Wang, L., Vogl, T., and Srikrichna, G. (2011). S100A8/A9 acrivate key genes and pathways in colon tumor progression. Mol. Cancer Res. 9, 133–148.

    Article  PubMed  CAS  Google Scholar 

  • Joyce, J.A., and Pollard, J.W. (2009). Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9, 239–252.

    Article  PubMed  CAS  Google Scholar 

  • Kerkela, E., Ala-aho, R., Klemi, P., Grenman, S., Shapiro, S.D., Kahari, V.M., and Saarialho-Kere, U. (2002). Metalloelastease (MMP-12) expression by tumour squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome. J. Pathol. 198, 258–269.

    Article  PubMed  CAS  Google Scholar 

  • Li, J., Lau, G.K., Chen, L., Dong, S.S., Lan, H.Y., Huang, X.R., Li, Y., Luk, J.M., Yuan, Y.F., and Guan, X.Y. (2011). Interlukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression. PLoS One 6, e21816.

    Article  PubMed  CAS  Google Scholar 

  • Moon, A., Yong, H.Y., Song, J.I., Cukovic, D., Salagrama, S., Kaplan, D., Putt, D., Kim, H., Dombkowski, A., and Kim, H.R. (2008). Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion. Mol. Cancer Res. 6, 1544–1553.

    Article  PubMed  CAS  Google Scholar 

  • Nacken, W., and Kerkhoff, C. (2007). The hetero-oligomeric complex of the S100A8/A9 protein is extremely protease resistant. FEBS Lett. 581, 5127–5130.

    Article  PubMed  CAS  Google Scholar 

  • Nacken, W., Roth, J., Sorg, C., and Kerkhoff, C. (2003). S100A9/S100A8: Myeloid representative of the S100 protein family ac prominent players in innate immunity. Microsc. Res. Tech. 60, 569–580.

    Article  PubMed  CAS  Google Scholar 

  • Ng, K.T., Qi, X., Kong, K.L., Cheung, B.Y., Lo, C.M., Poon, R.T., Fan, S.T., and Man, K. (2011). Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma. Eur. J. Cancer 47, 2299–2305.

    Article  PubMed  CAS  Google Scholar 

  • Rao, J.S. (2003). Molecular mechanisms of glioma invasiveness: the role of proteases. Nat. Rev. Cancer 3, 489–501.

    Article  PubMed  CAS  Google Scholar 

  • Roth, J., Goebeler, M., and Sorg, C. (2001). S100A8 and S100A9 in inflammatory diseases. Lancet 257, 1041.

    Article  Google Scholar 

  • Roth, J., Vogl, T., Sorg, C., and Sunderkötter, C. (2003). Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol. 24, 155–158.

    Article  PubMed  CAS  Google Scholar 

  • Roy, R., Yang, J., and Moses, M.A. (2009). Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J. Clin. Oncol. 27, 5287–5297.

    Article  PubMed  CAS  Google Scholar 

  • Rychman, C., Vandal, K., Rouleau, P., Talbot, M., and Tessier, P.A. (2003). Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutophilchemotaxis and adhesion. J. Immunol. 170, 3233–3242.

    Google Scholar 

  • Salama, I., Malone, P.S., Mihaimeed, F., and Jones, J.L. (2008). A review of the S100 proteins in cancer. Eur. J. Surg. Oncol. 34, 357–364.

    Article  PubMed  CAS  Google Scholar 

  • Sheikh, A.A., Vimalachandran, D., Thompson, C.C., Jenkins, R.E., Nedjadi, T., Shekouh, A., Campbell, F., Dodson, A., Prime, W., Crnogorac-Jurcevic, T., et al. (2007). The expression of S100A8 in pancreatic cancer-associated monocyte is associated with the Smad4 status of pancreatic cancer cells. Proteomics 7, 1929–1940.

    Article  PubMed  CAS  Google Scholar 

  • Silva, D. (2004). Signaling pathways responsible for cancer cell invasion as targets for cancer therapy. Curr. Cancer Drug Targets 4, 327–336.

    Article  Google Scholar 

  • Smith, M.G., Hold, G.L., Tahara, E., and El-Omar, E.M. (2006). Cellular and molecular aspects of gastric cancer. World J. Gastroenterol. 12, 2979–2990.

    PubMed  CAS  Google Scholar 

  • Takada, Y., Singh, S., and Aggarwal, B.B. (2004). Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in downregulation of NF-kappaB-mediated gene expression and upregulation of apoptosis. J. Biol. Chem. 279, 15096–15104.

    Article  PubMed  CAS  Google Scholar 

  • Turovskaya, O., Foell, D., Shiha, P., Vogl, T., Newlin, R., Nayak, J., Nguyen, M., Olsson, A., Nawroth, P.P., Bierhus, A., et al. (2008). RAGE, carboxylatedglycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis 29, 2035–2043.

    Article  PubMed  CAS  Google Scholar 

  • Whiteside, T.L. (2008). The tumor microenvironment and its role in promoting tumor growth. Oncogene 27, 5904–5912.

    Article  PubMed  CAS  Google Scholar 

  • Yong, H.Y., and Moon, A. (2007). Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells. Arch. Pharm. Res. 30, 75–81.

    Article  PubMed  CAS  Google Scholar 

  • Zhao, Z.S., Wang, Y.Y., Chu, Y.Q., Ye, Z.Y., and Tao, H.Q. (2010). SPARC is associated with gastric cancer progression and poor survival of patients. Clin. Cancer Res. 16, 260–268.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Do Youn Park.

About this article

Cite this article

Kwon, C.H., Moon, H.J., Park, H.J. et al. S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells. Mol Cells 35, 226–234 (2013). https://doi.org/10.1007/s10059-013-2269-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10059-013-2269-x

Keywords

Navigation